References
- Kamme C., Kahlmeter G., Melander A. Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Scand. J. Infect. Dis. 1978; 10: 135–1421. Kamme C., Kahlmeter G., Melander A. Evaluation of spiramycin as a therapeutic agent for elimination of nasopharyngeal pathogens. Scand. J. Infect. Dis. 1978; 10: 135–142
- Kucers A. “The Use of Antibiotics”. Heinemann, London 1972; 207–2272. Kucers A. “The Use of Antibiotics”. Heinemann, London 1972; 207–227
- Maniar A. C., Eidus L., Greenberg L. A comparison of in vitro and in vivo activity of erythromycin and spiramycin. Antibiot. Chemother. 1960; 10: 726–7303. Maniar A. C., Eidus L., Greenberg L. A comparison of in vitro and in vivo activity of erythromycin and spiramycin. Antibiot. Chemother. 1960; 10: 726–730
- Schmid E. F. The macrolide group of antibiotics. Antibiot. Chemother. 1971; 17: 52–664. Schmid E. F. The macrolide group of antibiotics. Antibiot. Chemother. 1971; 17: 52–66
- Wade A. “Martindale. The Extra Pharmacopoeia”, 27th edit. Pharmaceutical Press, London 1978; 1131–11805. Wade A. “Martindale. The Extra Pharmacopoeia”, 27th edit. Pharmaceutical Press, London 1978; 1131–1180